Reach Us +1-504-608-2390
Tissue-specific Auto Antibodies In Systemic Lupus Erythematosus | 3408
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Tissue-specific auto antibodies in systemic lupus erythematosus

International Conference on Clinical & Cellular Immunology

Kaihong Su

ScientificTracks Abstracts: J Clin Cell Immunol

DOI: 10.4172/2155-9899.S1.002

Systemic lupus erythematosus (SLE) is a chronic complex autoimmune disease involving multi-organ and organ systems. At the devastating disease stage, abnormal immune response can lead to vital damage to the kidneys, brain, heart, blood vessels, and lungs. Although anti-nuclear auto antibodies have been shown to play an important role in SLE disease pathogenesis, the types of auto antibodies causing specific end-organ manifestations are still unclear. To identify auto antibodies that may lead to organ-specific damage in SLE, we generated a large panel of recombinant monoclonal antibodies from SLE patients using the advanced single cell RT-PCR technology. We screened the recombinant antibodies for their reactivity to different tissue cells including neutrophils, blood vessel endothelial cells, and neuronal cells. For the antibodies that react with those cells, protein array or immunoprecipitation assays followed by mass spectrometry analysis are performed to identify their cognate antigens. In particular, we have identified that SLE-derived S4Ab2 antibody recognizes membrane bound protein disulfide isomerase (PDI) and S4Ab4 antibody recognizes a novel pattern recognition receptor NLRC5/NOD27. Administration of either antibody in NZB/W F1 lupus-prone mice induced transient proteinuria and kidney damage. Furthermore, SLE patients with active disease have increased titers of anti-PDI and anti-NLRC5 antibodies in their sera. Our studies suggest that anti-PDI and anti-NLRC5 auto antibodies may play an important role in the disease progression and organ damage in SLE patients.

Kaihong Su obtained her doctorate degree and post-doctoral training from the University of Alabama at Birmingham (UAB). After being a faculty member at UAB for 5 years, she joined the University of Nebraska Medical Center in 2008 to continue her research. The long-term goal of her lab is to understand the molecular mechanisms for autoimmune diseases, including SLE and RA. She has published 26 papers in reputed journals and served as ad-hoc reviewers for a number of scientific journals.